Category: breach of ethical policy

Authors retract two neuroscience papers for duplication and plagiarism

Journal of NeurosurgeryA tipster’s complaints have led to the retraction of two papers in the Journal of Neurosurgery for “plagiarism, duplicate publication, and copyright infringement.”

The corresponding author for both papers, Hung-Chuan Pan of Taichung Veterans General Hospital, had contacted the journal about publishing an erratum for one of the articles when the journal was tipped off by an email pointing out deeper problems in the two retracted papers.

The tipster provided evidence that alleged “a violation of ethics on the part of the authors,” according to the communications manager at the JNS Publishing Group, Jo Ann Eliason.

Both retraction notices, published October 2, detailed a number of “similarities” and “overlaps” in the papers.

Continue reading Authors retract two neuroscience papers for duplication and plagiarism

BMC investigating allegedly copied paper

logoBioMed Central is investigating a recent paper about a potential biomarker for liver cancer, which shows signs it was written using another article as a template.

According to Jeffrey Beall, who exposed the similarities between the two papers on his blog Scholarly Open Access yesterday, the paper in question is “obviously bogus,” and appears to have relied on the “template plagiarism” technique of creating a new article by modifying a previous paper’s text and data.

A spokesperson for BioMed Central, which published the allegedly “junk” paper, as Beall calls it, told us they are looking into the allegations: Continue reading BMC investigating allegedly copied paper

“Insufficient permission” from funder resects liver disease paper

HepatologyA study on chronic liver inflammation was pulled from the journal Hepatology because of “insufficient permission by the authors’ funding institution to submit and publish the manuscript.” 

The paper, which was published in July, looked into how steatosis, the abnormal retention of fat in the liver, turns into steatohepatitis, also known as fatty liver disease. Researchers found that Treg cells play a central role in controlling the disease.

Unfortunately, the journal’s managing editor didn’t provide any information about the nature of the permission problems, and the notice doesn’t give any details.

Here it is, in full:

Continue reading “Insufficient permission” from funder resects liver disease paper

Boldt’s retraction count upped to 94, co-author takes legal action to prevent 95th

Screen Shot 2015-09-16 at 12.12.13 AM

We’ve found two recent retractions and an expression of concern for Joachim Boldt, former prominent anesthesiologist and currently Retraction Watch leaderboard’s 2nd place titleholder. He now has 94 retractions.

One of the retracted articles contains falsified data, along with a researcher who didn’t agree to be a co-author, according to an investigation by the Justus Liebig University Giessen, where Boldt used to work. The expression of concern is regarding some questionable data. The other new retraction is actually one of 88 papers that a group of editors agreed to retract back in 2011, after they were “unable to verify” approval by the Institutional Review Board (IRB) for the studies.

One of those 88 papers, we’ve discovered, has still has not been retracted. According to an editor at the journal, they haven’t removed it because one of Boldt’s co-authors has threatened them with legal action. Continue reading Boldt’s retraction count upped to 94, co-author takes legal action to prevent 95th

Animal welfare breach prompts Nature correction

cover_nature (1)A 2011 letter to Nature from Harvard researchers received its second correction today, this time after discovering the researchers conducted experiments in which mice may have “experienced more pain and suffering than originally allowed for.”

That quote comes from an accompanying editorial in the journal, a rare move for a correction to a 2011 letter. But it’s an unusual correction, for a letter that found that a component of a pepper plant appeared to selectively kill cancer cells, leaving healthy cells relatively unscathed.

Here’s the first paragraph from the detailed correction notice, published today: Continue reading Animal welfare breach prompts Nature correction

Authors’ pharma ties cause Cochrane to withdraw two diabetes reviews

Cochrane_LogoThe Cochrane Library has withdrawn two reviews evaluating the effectiveness of diabetes treatments because some of the papers’ authors work with pharmaceutical companies.

Bianca Hemmingsen, first author on both reviews, told us the Cochrane Library asked the authors to remove the researchers with ties to pharma, but after one “refused to withdraw,” both papers were pulled entirely.

However, Hemmingsen insists that their employment had no impact on either paper.

This breaks the typical mold for Cochrane withdrawals, which are usually only pulled to indicate updates and show that older reviews no longer represent the best evidence.

Continue reading Authors’ pharma ties cause Cochrane to withdraw two diabetes reviews

Researchers suspended in Japan for funding violations

Sanae Ariga
Sanae Ariga

Hokkaido University has suspended two of its professors after an investigation found “improper receipt of research funding.”

One member of the team was awarded more than 15 million yen (roughly $120,000 USD) in research grants from the Japan Society for the Promotion of Science (JSPS), according to the official statement (translated by One Hour Translation).

The researchers share a last name. Hiroyoshi Ariga, a professor of Biomedical and Pharmaceutical Science and the head of a university lab, was given 8 million yen in 2006 and 7.5 million in 2007. It appears that Sanae Ariga also received funds for a similar study, based on the translation:

Continue reading Researchers suspended in Japan for funding violations

“Unethical behavior” breaks crystallography paper

Molecules and Cells

A 2011 paper about the crystal structure of a transcription regulator has been pulled by Molecules and Cells for “unethical behavior by the authors.”

Unfortunately, we can’t say much more than that, because the notice doesn’t, either: Continue reading “Unethical behavior” breaks crystallography paper

Golden rice paper pulled after judge rules for journal

home_coverThe American Journal of Clinical Nutrition is retracting a paper that showed genetically engineered rice serves as an effective vitamin A supplement after a Massachusetts judge denied the first author’s motion for an injunction against the publisher.

The journal announced plans to retract the paper last year following allegations that the paper contained ethical mis-steps, such as not getting informed consent from the parents of children eating the rice, and faking ethics approval documents.

Last July, first author Guangwen Tang at Tufts University filed a complaint and motion for preliminary injunction against the journal’s publisher, the American Society for Nutrition, to stop the retraction.

According to the ASN, on July 17, a Massachusetts Superior Court “cleared the way” for the publisher to retract the paper. So they have, as of July 29. Here’s more from the retraction notice:

Continue reading Golden rice paper pulled after judge rules for journal

Retraction of monkey paper linked to problems at shuttered research institute

Veterinary Pathology.Evidence of poorly treated lab animals has led researchers to retract a 2014 article in Veterinary Pathology that explored the neurological effects of dehydration in squirrel monkeys.

The study was pulled after Frederick Wang, the former director of the New England Primate Research Center, unveiled reports of a dozen squirrel monkeys that were found dehydrated and dead in their cages or euthanized between 1999 and 2011.

Wang told the Boston Globe in April that “human error” and “inadequate animal care” might have compromised the results of the study:

Continue reading Retraction of monkey paper linked to problems at shuttered research institute